CECentral.com

(1 of 5) Adv.


(1 of 5) Adv.

Lawrence Rice, MD
Lawrence Rice, MD Dr. Lawrence Rice is Professor of Medicine in Hematology and Thrombosis Research. He has been Program Director of Hematology... Read More
Hatim Omar, MD, FAAP
Hatim Omar, MD, FAAP Dr. Omar is a Professor in Pediatrics and Obstetrics Gynecology and Director of Adolescent Medicine and Young Parent Program at the University of Kentucky in Lexington, Kentucky. Read More
Elliott M. Antman, MD, FACC
Elliott M. Antman, MD, FACC Dr. Antman is director of the Samuel A. Levine Cardiac Unit in the Cardiovascular Division of the Brigham and Women's Hospital in Boston, Massachusetts. Read More
Arthur Kavanaugh, MD
Arthur Kavanaugh, MD Dr. Kavanaugh is Professor of Medicine at The University of California at San Diego, School of Medicine and the Director of the Center for Innovative Therapy in Division of Rheumatology, Allergy and Immunology. Read More

Pharmacist Counter-Terrorism Preparedness Module 2: Focusing on Potential Bacterial Weapons

1.00CPE
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better prepared to fully participate in these efforts. All healthcare systems, including both the public and private...  Read More

This activity presented by...

Robert P. Rapp, PharmD, FCCP Associate Director of Pharmacy Services
Clinical Pharmacy Specialist for Infectious Diseases ...
Robert P Rapp, PharmD, FCCP

The Continuing Emergence of MRSA

1.00CME
Methicillin-resistant Staphylococcus aureus (MRSA) first appeared less than one year after the clinical introduction of methicillin. Despite this early appearance, MRSA did not become a significant and common clinical problem until the 1980s. Since that time, national rates of MRSA past 50%. In addition, a new therapeutic dilemma has emerged; that of community-associated MRSA (caMRSA). This emergence has brought new complexity to the diagnosis and treatment of outpatient infections,...  Read More

This activity presented by...

Craig Martin, PharmD, BCPS Clinical Pharmacy Specialist in Infectious Diseases, UKMC, Assistant Professor, Pharmacy,
UK...
Craig Martin, PharmD, BCPS

Roundtable #1: Antimicrobial Resistance: A Historical Perspective On A Current Threat

1.00CME
1.20CPE

Drug resistant organisms have increased across the globe and represent a major threat to the health of hospitalized patients. Overuse and improper use of certain antibiotic drug classes as well as failure to take infection control measures in hospitals has led to a major nosocomial infection problem in the United States. Antimicrobials account for upwards of 30% of hospital pharmacy budgets. It has been recognized for several decades that up to 50% of antimicrobial use is inappropriate,...  Read More

This activity presented by...

View All Meetings

© 2008 University of Kentucky, Colleges of Pharmacy & Medicine
Privacy Statement · Feedback · About CECentral.com